Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Breast Cancer · Prostate Cancer · UTHR

United Therapeutics Europe

United Therapeutics Europe Ltd

United Therapeutics Europe clinical programs — 1032 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
1032
Drugs
612
Patents
3720
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

United Therapeutics Europe projects

1,032 ClinicalTrials.gov programs sponsored by United Therapeutics Europe.

United Therapeutics Europe has 1,032 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,032 programs

Clinical programs

Page 14 of 22

  1. Losartan potassium 50mg

    United Therapeutics Europe Ltd

    Emotional Processing

    phase 1 small molecule active

    1 trial

  2. Losartan potassium 50mg

    United Therapeutics Europe Ltd

    Social Cognition

    phase 1 small molecule active

    1 trial

  3. Lumason Contrast-Enhanced Ultrasound

    United Therapeutics Europe Ltd

    Kidney Transplantation

    phase 1 small molecule terminated

    1 trial

  4. Lumason® contrast agent

    United Therapeutics Europe Ltd

    Mitochondrial Myopathies

    phase 1 small molecule active

    1 trial

  5. MGD020

    United Therapeutics Europe Ltd

    HIV (Human Immunodeficiency Virus)

    phase 1 small molecule active

    1 trial

  6. Magellan®

    United Therapeutics Europe Ltd

    Acute Burns

    phase 1 other active

    1 trial

  7. Mammaglobin-A DNA Vaccine

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 1 mab active

    1 trial

  8. MapMySmoke

    United Therapeutics Europe Ltd

    Smoking

    phase 1 other active

    1 trial

  9. Metformin

    United Therapeutics Europe Ltd

    Tendinopathy

    phase 1 small molecule active

    1 trial

  10. Minocycline

    United Therapeutics Europe Ltd

    Alcohol Dependence

    phase 1 small molecule completed

    1 trial

  11. Mirasol System for Whole Blood.

    United Therapeutics Europe Ltd

    Healthy

    phase 1 mab terminated

    1 trial

  12. N-Acetylcysteine

    United Therapeutics Europe Ltd

    Mitochondrial Disease

    phase 1 small molecule active

    1 trial

  13. NDV-3 vaccine with alum IM

    United Therapeutics Europe Ltd

    Staphylococcal Infections

    phase 1 mab completed

    1 trial

  14. Nanosensor

    United Therapeutics Europe Ltd

    MItochondrial Myopathies

    phase 1 other active

    1 trial

  15. Nivolumab

    United Therapeutics Europe Ltd

    Ovarian Cancer

    phase 1 small molecule active

    1 trial

  16. Norovirus

    United Therapeutics Europe Ltd

    Healthy Adults

    phase 1 mab completed

    1 trial

  17. ONX-0801

    United Therapeutics Europe Ltd

    Solid Tumours

    phase 1 small molecule completed

    1 trial

  18. Oxymetazoline

    United Therapeutics Europe Ltd

    Fecal Incontinence

    phase 1 small molecule active

    1 trial

  19. Oxytocin

    United Therapeutics Europe Ltd

    Unit Cohesion

    phase 1 small molecule completed

    1 trial

  20. P3C541b Lipopeptide

    United Therapeutics Europe Ltd

    HIV Infections

    phase 1 mab completed

    1 trial

  21. PKE LPSpilot

    United Therapeutics Europe Ltd

    Cardiovascular Disease

    phase 1 small molecule completed

    1 trial

  22. PLX-PAD

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 1 small molecule terminated

    1 trial

  23. PNT001

    United Therapeutics Europe Ltd

    Traumatic Brain Injury

    phase 1 mab terminated

    1 trial

  24. PSA/IL-2/GM-CSF

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 1 mab active

    1 trial

  25. PVSRIPO

    United Therapeutics Europe Ltd

    Invasive Breast Cancer

    phase 1 mab completed

    1 trial

  26. Palbociclib + Taselisib / Pictilisib

    United Therapeutics Europe Ltd

    Advanced Solid Tumours

    phase 1 small molecule completed

    1 trial

  27. Pembrolizumab

    United Therapeutics Europe Ltd

    Thoracic Tumours

    phase 1 small molecule completed

    1 trial

  28. Pembrolizumab

    United Therapeutics Europe Ltd

    Cervix Cancer

    phase 1 other terminated

    1 trial

  29. Physical Activity Educational Materials

    United Therapeutics Europe Ltd

    Physical Inactivity

    phase 1 other completed

    1 trial

  30. Pitavastatin

    United Therapeutics Europe Ltd

    Acute Myeloid Leukemia

    phase 1 small molecule completed

    1 trial

  31. Placebo Intravaginal Ring A

    United Therapeutics Europe Ltd

    Safety

    phase 1 other terminated

    1 trial

  32. Placebo Vaginal Film with Square Corners

    United Therapeutics Europe Ltd

    Safety

    phase 1 small molecule completed

    1 trial

  33. Plasmodium falciparum Malaria Protein 010 (FMP010)

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  34. Plerixafor

    United Therapeutics Europe Ltd

    Pancreatic Adenocarcinoma Metastatic

    phase 1 small molecule completed

    1 trial

  35. Pramipexole

    United Therapeutics Europe Ltd

    Parkinson Disease

    phase 1 small molecule completed

    1 trial

  36. Protexia

    United Therapeutics Europe Ltd

    Intervention for Nerve Agent Exposure

    phase 1 mab completed

    1 trial

  37. Provision of extra (care coordination and management) services

    United Therapeutics Europe Ltd

    Hospitalization

    phase 1 other completed

    1 trial

  38. Psilocybin

    United Therapeutics Europe Ltd

    Amyotrophic Lateral Sclerosis

    phase 1 small molecule active

    1 trial

  39. Q-Griffithsin

    United Therapeutics Europe Ltd

    COVID-19 Prevention

    phase 1 small molecule completed

    1 trial

  40. Q-Griffithsin 3.0

    United Therapeutics Europe Ltd

    COVID-19 Prevention

    phase 1 small molecule active

    1 trial

  41. Rehabilitation

    United Therapeutics Europe Ltd

    Stroke

    phase 1 other completed

    1 trial

  42. SOM 230 / Pasireotide

    United Therapeutics Europe Ltd

    Atypical Ductal Breast Hyperplasia

    phase 1 small molecule completed

    1 trial

  43. Shigella sonnei 53G

    United Therapeutics Europe Ltd

    Shigellosis

    phase 1 mab active

    2 trials

  44. Shigella sonnei 53G

    United Therapeutics Europe Ltd

    Healthy

    phase 1 mab completed

    1 trial

  45. Simvastatin

    United Therapeutics Europe Ltd

    Recurrent Acute Pancreatitis

    phase 1 small molecule active

    1 trial

  46. TAF/EVG Vaginal Insert

    United Therapeutics Europe Ltd

    Hiv

    phase 1 small molecule completed

    1 trial

  47. TAF/EVG vaginal insert

    United Therapeutics Europe Ltd

    Safety Issues

    phase 1 small molecule completed

    1 trial

  48. Tepotinib

    United Therapeutics Europe Ltd

    Advanced Cancer

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does United Therapeutics Europe have?

1,032 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.